BirlaNu Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 22, 2025, 3:57 am

Competitors of BirlaNu Ltd

All Competitor Stocks of BirlaNu Ltd

Quarterly Result

Last Updated: August 11, 2025, 10:16 am

Below is a detailed analysis of the quarterly data for BirlaNu Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,052.28 Cr.. The value appears strong and on an upward trend. It has increased from 928.91 Cr. (Mar 2025) to 1,052.28 Cr., marking an increase of 123.37 Cr..
• For Expenses, as of Jun 2025, the value is 1,012.60 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 906.50 Cr. (Mar 2025) to 1,012.60 Cr., marking an increase of 106.10 Cr..
• For Operating Profit, as of Jun 2025, the value is 39.68 Cr.. The value appears strong and on an upward trend. It has increased from 22.41 Cr. (Mar 2025) to 39.68 Cr., marking an increase of 17.27 Cr..
• For OPM %, as of Jun 2025, the value is 3.77%. The value appears strong and on an upward trend. It has increased from 2.41% (Mar 2025) to 3.77%, marking an increase of 1.36%.
• For Other Income, as of Jun 2025, the value is 19.39 Cr.. The value appears strong and on an upward trend. It has increased from 10.04 Cr. (Mar 2025) to 19.39 Cr., marking an increase of 9.35 Cr..
• For Interest, as of Jun 2025, the value is 16.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.57 Cr. (Mar 2025) to 16.89 Cr., marking an increase of 0.32 Cr..
• For Depreciation, as of Jun 2025, the value is 37.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.69 Cr. (Mar 2025) to 37.00 Cr., marking an increase of 1.31 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.18 Cr.. The value appears strong and on an upward trend. It has increased from -19.81 Cr. (Mar 2025) to 5.18 Cr., marking an increase of 24.99 Cr..
• For Tax %, as of Jun 2025, the value is 125.48%. The value appears to be increasing, which may not be favorable. It has increased from 24.73% (Mar 2025) to 125.48%, marking an increase of 100.75%.
• For Net Profit, as of Jun 2025, the value is -1.32 Cr.. The value appears strong and on an upward trend. It has increased from -24.71 Cr. (Mar 2025) to -1.32 Cr., marking an increase of 23.39 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.75. The value appears strong and on an upward trend. It has increased from -32.77 (Mar 2025) to -1.75, marking an increase of 31.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 11, 2025, 10:16 am

Growth

Last Updated: September 5, 2025, 6:05 am

Balance Sheet

Last Updated: August 11, 2025, 10:16 am

Below is a detailed analysis of the balance sheet data for BirlaNu Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,204.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,245.00 Cr. (Mar 2024) to 1,204.00 Cr., marking a decrease of 41.00 Cr..
• For Borrowings, as of Mar 2025, the value is 959.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 776.00 Cr. (Mar 2024) to 959.00 Cr., marking an increase of 183.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 749.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 714.00 Cr. (Mar 2024) to 749.00 Cr., marking an increase of 35.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,920.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,743.00 Cr. (Mar 2024) to 2,920.00 Cr., marking an increase of 177.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,684.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,410.00 Cr. (Mar 2024) to 1,684.00 Cr., marking an increase of 274.00 Cr..
• For CWIP, as of Mar 2025, the value is 57.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2024) to 57.00 Cr., marking an increase of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 104.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 104.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,178.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,182.00 Cr. (Mar 2024) to 1,178.00 Cr., marking a decrease of 4.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,920.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,743.00 Cr. (Mar 2024) to 2,920.00 Cr., marking an increase of 177.00 Cr..

Notably, the Reserves (1,204.00 Cr.) exceed the Borrowings (959.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for BirlaNu Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -43.63. This value is below the healthy minimum of 5. It has decreased from 46.15 (Mar 24) to -43.63, marking a decrease of 89.78.
• For Diluted EPS (Rs.), as of Mar 25, the value is -43.63. This value is below the healthy minimum of 5. It has decreased from 46.15 (Mar 24) to -43.63, marking a decrease of 89.78.
• For Cash EPS (Rs.), as of Mar 25, the value is 148.32. This value is within the healthy range. It has decreased from 205.31 (Mar 24) to 148.32, marking a decrease of 56.99.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,600.73. It has decreased from 1,655.42 (Mar 24) to 1,600.73, marking a decrease of 54.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,600.73. It has decreased from 1,655.42 (Mar 24) to 1,600.73, marking a decrease of 54.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 4,776.93. It has increased from 4,459.46 (Mar 24) to 4,776.93, marking an increase of 317.47.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 116.34. This value is within the healthy range. It has decreased from 203.86 (Mar 24) to 116.34, marking a decrease of 87.52.
• For PBIT / Share (Rs.), as of Mar 25, the value is -74.04. This value is below the healthy minimum of 0. It has decreased from 45.28 (Mar 24) to -74.04, marking a decrease of 119.32.
• For PBT / Share (Rs.), as of Mar 25, the value is -56.00. This value is below the healthy minimum of 0. It has decreased from 47.73 (Mar 24) to -56.00, marking a decrease of 103.73.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -42.05. This value is below the healthy minimum of 2. It has decreased from 46.73 (Mar 24) to -42.05, marking a decrease of 88.78.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -43.48. This value is below the healthy minimum of 2. It has decreased from 45.96 (Mar 24) to -43.48, marking a decrease of 89.44.
• For PBDIT Margin (%), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 10. It has decreased from 4.57 (Mar 24) to 2.43, marking a decrease of 2.14.
• For PBIT Margin (%), as of Mar 25, the value is -1.54. This value is below the healthy minimum of 10. It has decreased from 1.01 (Mar 24) to -1.54, marking a decrease of 2.55.
• For PBT Margin (%), as of Mar 25, the value is -1.17. This value is below the healthy minimum of 10. It has decreased from 1.07 (Mar 24) to -1.17, marking a decrease of 2.24.
• For Net Profit Margin (%), as of Mar 25, the value is -0.88. This value is below the healthy minimum of 5. It has decreased from 1.04 (Mar 24) to -0.88, marking a decrease of 1.92.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.91. This value is below the healthy minimum of 8. It has decreased from 1.03 (Mar 24) to -0.91, marking a decrease of 1.94.
• For Return on Networth / Equity (%), as of Mar 25, the value is -2.71. This value is below the healthy minimum of 15. It has decreased from 2.77 (Mar 24) to -2.71, marking a decrease of 5.48.
• For Return on Capital Employeed (%), as of Mar 25, the value is -3.13. This value is below the healthy minimum of 10. It has decreased from 1.82 (Mar 24) to -3.13, marking a decrease of 4.95.
• For Return On Assets (%), as of Mar 25, the value is -1.12. This value is below the healthy minimum of 5. It has decreased from 1.26 (Mar 24) to -1.12, marking a decrease of 2.38.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has decreased from 0.25 (Mar 24) to 0.21, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has increased from 0.43 (Mar 24) to 0.58, marking an increase of 0.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.28. It has decreased from 1.32 (Mar 24) to 1.28, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1.5. It has decreased from 1.41 (Mar 24) to 0.97, marking a decrease of 0.44.
• For Quick Ratio (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.37, marking a decrease of 0.21.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.74. This value is below the healthy minimum of 4. It has increased from 2.53 (Mar 24) to 2.74, marking an increase of 0.21.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -51.56. This value is below the healthy minimum of 20. It has decreased from 86.68 (Mar 24) to -51.56, marking a decrease of 138.24.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.26. This value is below the healthy minimum of 20. It has decreased from 19.48 (Mar 24) to 15.26, marking a decrease of 4.22.
• For Earning Retention Ratio (%), as of Mar 25, the value is 151.56. This value exceeds the healthy maximum of 70. It has increased from 13.32 (Mar 24) to 151.56, marking an increase of 138.24.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.74. This value exceeds the healthy maximum of 70. It has increased from 80.52 (Mar 24) to 84.74, marking an increase of 4.22.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 3. It has decreased from 4.36 (Mar 24) to 1.29, marking a decrease of 3.07.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.66. This value is below the healthy minimum of 3. It has decreased from 0.94 (Mar 24) to -0.66, marking a decrease of 1.60.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,994.28. It has decreased from 2,382.29 (Mar 24) to 1,994.28, marking a decrease of 388.01.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.70 (Mar 24) to 0.55, marking a decrease of 0.15.
• For EV / EBITDA (X), as of Mar 25, the value is 22.65. This value exceeds the healthy maximum of 15. It has increased from 15.44 (Mar 24) to 22.65, marking an increase of 7.21.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.37, marking a decrease of 0.21.
• For Retention Ratios (%), as of Mar 25, the value is 151.56. This value exceeds the healthy maximum of 70. It has increased from 13.31 (Mar 24) to 151.56, marking an increase of 138.25.
• For Price / BV (X), as of Mar 25, the value is 1.13. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.13, marking a decrease of 0.44.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.37, marking a decrease of 0.21.
• For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.02, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness